(Wednesday, 7/17/2019) 4:30 PM - 6:00 PM
Room: Stars at Night Ballroom 2-3
The World Health Organization states that cardiovascular disease (CVD) is the number one cause of death globally. 18 million people die from CVD annually, with 85% due to heart attack and stroke. To address this worldwide problem a tremendous amount of research and development is invested in prevention, early detection and treatment. These research streams span education campaigns, point of care diagnostics, epidemiology, genetics, artificial intelligence, fluid dynamics, systems modelling, smart implantable technology, drug discovery, signal processing, advanced imaging and novel therapeutics. This joint imaging/therapy scientific session will cover some of these advances, focusing on areas that medical physicists are heavily involved in, including the repurposing of devices that are traditionally used for cancer treatment to CVD treatments.
The session will begin with a general discussion of cardiac imaging and interventional applications followed by two disease-specific presentations on x-ray and MRI guided-ablative radiotherapy to treat atrial fibrillation and the clinical experience, technical challenges and future plans for using image guided radiation therapy to treat ventricular tachycardia. Audience questions will be answered in a panel discussion.
Learning objectives:
1. Understand the global burden of cardiovascular disease
2. Understand x-ray and MRI technology being developed to assist with the imaging and treatment of cardiovascular disease
3. Understand the role that medical physicists can play in advance new technologies for the imaging and treatment of cardiovascular disease
Ref: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) [Accessed 2010-03-25]
Funding Support, Disclosures, and Conflict of Interest: Conflicts disclosed to the AAPM and publicly disclosed and updated at http://sydney.edu.au/medicine/image-x/about/disclosures.php
Keywords
Not Applicable / None Entered.
Taxonomy
Not Applicable / None Entered.
Contact Email
